Oxford Biosensors Ltd Company Profile

21:29 EDT 22nd March 2018 | BioPortfolio

Since formation in 2000, Oxford Biosensors has invested significant resources into the commercialisation of biosensor technology. The groundbreaking technical advances achieved through an intensive R & D programme have resulted in the development of a range of low complexity, hand-held diagnostic products.
Set to satisfy the demand for fast and accurate multi-parameter analysis at the point of care, the company's Multisense dry enzyme system provides essential diagnostic results instantly.
Oxford Biosensors' interdisciplinary development programme is led by top research and development scientists and brings together expertise in electronics, materials science, electrochemistry and enzyme technology. In addition, a group of respected and internationally recognised experts sit on the company's advisory boards alongside other distinguished academics and medics.


Oxford Industrial Park Mead Road
United Kingdom


Phone: 44 (0)1865 849 100
Fax: 44 (0)1865 849 200

News Articles [274 Associated News Articles listed on BioPortfolio]

Global Biosensors for Point-of-Care Testing Markets 2017-2027 - A Potential $33 Billion Industry

The report predicts that point-of-care biosensors will become a $33 billionmarket by 2027, with molecular diagnostic devices the main driver for this growth. Biosensors Read more...

Biosensors Bring HIV Test to Patients for Instant Results

A report on the use of biosensors in molecular disease diagnostics states the technology could significantly reduce the spread of HIV. A report by Cambridge-based IDTechEx analyzed important trends i...

Oxford mothers-to-be learn about gestational diabetes research

Oxford researchers have attended two events in Oxford to let pregnant women know how to have a healthy pregnancy and to ask them to get involved in giving their views on future research. The researche...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has s...

Easy printing of biosensors made of graphene

Cell-based biosensors can simulate the effect of various substances, such as drugs, on the human body in the laboratory. Depending on the measuring principle, though, producing them can be expensive....

Transcription factor‐based biosensors in high‐throughput screening: advances and applications

The molecular mechanisms that cells use to sense changes in the intra‐ and extracellular environment are increasingly utilized in synthetic biology to build genetic reporter constructs for various a...

Oxford Immunotec: Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit

Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation OXF...

Drugs and Medications [0 Results]


PubMed Articles [837 Associated PubMed Articles listed on BioPortfolio]

Gold nanoparticle-based colorimetric biosensors.

Gold nanoparticles (AuNPs) provide excellent platforms for the development of colorimetric biosensors as they can be easily functionalised, displaying different colours depending on their size, shape ...

Electrochemical biosensors for Salmonella: State of the art and challenges in food safety assessment.

According to the recent statistics, Salmonella is still an important public health issue in the whole world. Legislated reference methods, based on counting plate methods, are sensitive enough but are...

Recent advances in nanowires-based field-effect transistors for biological sensor applications.

Nanowires (NWs)-based field-effect transistors (FETs) have attracted considerable interest to develop innovative biosensors using NWs of different materials (i.e. semiconductors, polymers, etc.). NWs-...

Hyperspectral imaging for simultaneous measurements of two FRET biosensors in pancreatic β-cells.

Fluorescent protein (FP) biosensors based on Förster resonance energy transfer (FRET) are commonly used to study molecular processes in living cells. There are FP-FRET biosensors for many cellular mo...

Recent Progress in Biosensors for Environmental Monitoring: A Review.

The environmental monitoring has been one of the priorities at the European and global scale due to the close relationship between the environmental pollution and the human health/socioeconomic develo...

Clinical Trials [87 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [117 Associated Companies listed on BioPortfolio]

Oxford Biosensors Ltd

Since formation in 2000, Oxford Biosensors has invested significant resources into the commercialisation of biosensor technology. The groundbreaking technical advances achieved through an intensive R ...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

More Information about "Oxford Biosensors Ltd" on BioPortfolio

We have published hundreds of Oxford Biosensors Ltd news stories on BioPortfolio along with dozens of Oxford Biosensors Ltd Clinical Trials and PubMed Articles about Oxford Biosensors Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Biosensors Ltd Companies in our database. You can also find out about relevant Oxford Biosensors Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Corporate Database Quicklinks

Searches Linking to this Company Record